Schering-Plough taps China innovation through HUYA
This article was originally published in Scrip
Executive Summary
Schering-Ploughis looking to access China's growing innovative capability through a tie-up with HUYA Bioscience International. HUYA will exclusively provide to the US major's Organon subsidiary drug development candidates sourced from its network of Chinese research alliances.